Neurology
Neurology is a key segment within the Healthcare sector, comprising 3,836+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Neurology companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
Novel biopharmaceutical medicines are developed for unmet medical needs.
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
Developer of therapeutics for psychiatric and neurologic diseases
Biologics platform developed for intracellular delivery in rare diseases.
Developer of therapies for the treatment of musculoskeletal disorders
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
AI-driven drug discovery platform for neurological diseases based on patients biomarkers
Small molecule drugs for rare diseases are developed.
Developer of small molecule therapeutics for endocrine and CNS disorders
Developer of antibodies to treat complement-mediated neurodegenerative diseases
Precision medicines for neuropsychiatric and neurodegenerative disorders are developed.
Therapies for neurological and neuropsychiatric diseases are developed.
Portable EEG devices for point-of-care seizure diagnosis are provided.
Therapeutics for opioid addiction treatment are developed and commercialized.
Next-generation medicines for CNS and immunological disorders are developed.
Injectable non-opioid products for post-surgical pain control are developed.
Medical devices for neurological therapies are developed.
Developer of drug candidates for the treatment of rare CNS disorders
Gene therapies for ocular and neurodegenerative diseases are developed.
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
Explore Companies in Neurology
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies